J-Western forms of helicobacter pylori caga constitute a distinct phylogenetic group with a widespread geographic distribution

Journal of Bacteriology

Volumn 194, Issue 6, 2012, Pages 1593-1604

  Duncan, Stacy S ^a   Valk, Pieter L ^a   Shaffer, Carrie L ^a   Bordenstein, Seth R ^a,b   Cover, Timothy L ^a,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN;

5' UNTRANSLATED REGION; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; CONTROLLED STUDY; GENE SEQUENCE; GENETIC ANALYSIS; GEOGRAPHIC DISTRIBUTION; HELICOBACTER PYLORI; MICROBIAL POPULATION DYNAMICS; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CLUSTER ANALYSIS; DNA, BACTERIAL; EVOLUTION, MOLECULAR; GENETIC VARIATION; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; JAPAN; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; PHYLOGEOGRAPHY;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI;

EID: 84857949710     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.06340-11     Document Type: Article

References (65)

1. Abascal F, Zardoya R, Posada D. 2005. ProtTest: selection of best-fit models of protein evolution. Bioinformatics 21:2104 -2105.
2. Amieva MR, et al. 2003. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 300:1430 -1434.
3. Argent RH, Hale JL, El-Omar EM, Atherton JC. 2008. Differences in Helicobacter pylori CagA tyrosine phosphorylation motif patterns between western and East Asian strains, and influences on interleukin-8 secretion. J. Med. Microbiol. 57:1062-1067.
4. Atherton JC, Blaser MJ. 2009. Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J. Clin. Invest. 119:2475- 2487.
5. Atherton JC, et al. 1999. Simple and accurate PCR-based system for typing vacuolating cytotoxin alleles of Helicobacter pylori. J. Clin. Microbiol. 37:2979 -2982.
6. Azuma T, et al. 2004. Association between diversity in the Src homology 2 domain-containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer. J. Infect. Dis. 189: 820-827.
7. Backert S, Selbach M. 2005. Tyrosine-phosphorylated bacterial effector proteins: the enemies within. Trends Microbiol. 13:476-484.
8. Backert S, Tegtmeyer N, Selbach M. 2010. The versatility of Helicobacter pylori CagA effector protein functions: the master key hypothesis. Helicobacter 15:163-176.
9. Blaser MJ, Berg DE. 2001. Helicobacter pylori genetic diversity and risk of human disease. J. Clin. Invest. 107:767-773.
10. Blaser MJ, et al. 1995. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 55:2111-2115.
11. Botham CM, Wandler AM, Guillemin K. 2008. A transgenic Drosophila model demonstrates that the Helicobacter pylori CagA protein functions as a eukaryotic Gab adaptor. PLoS Pathog. 4:e1000064.
12. Bourzac KM, Guillemin K. 2005. Helicobacter pylori-host cell interactions mediated by type IV secretion. Cell Microbiol. 7:911-919.
13. Censini S, et al. 1996. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc. Natl. Acad. Sci. U. S. A. 93:14648 -14653.
14. Cortes MC, et al. 2010. Diversity of the cagA gene of Helicobacter pylori strains from patients with gastroduodenal diseases in the Philippines. FEMS Immunol. Med. Microbiol. 60:90 -97.
15. Covacci A, et al. 1993. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc. Natl. Acad. Sci. U. S. A. 90:5791-5795.
16. Cover TL, Blaser MJ. 2009. Helicobacter pylori in health and disease. Gastroenterology 136:1863-1873.
17. Crooks GE, Hon G, Chandonia JM, Brenner SE. 2004. WebLogo: a sequence logo generator. Genome Res. 14:1188 -1190.
18. Delgado-Rosado G, Dominguez-Bello MG, Massey SE. 2011. Positive selection on a bacterial oncoprotein associated with gastric cancer. Gut Pathog. 3:18.
19. de Sablet T, et al. 2011. Phylogeographic origin of Helicobacter pylori is a determinant of gastric cancer risk. Gut 60:1189 -1195.
20. Falush D, et al. 2003. Traces of human migrations in Helicobacter pylori populations. Science 299:1582-1585.
21. Figueiredo C, et al. 2002. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J. Natl. Cancer Inst. 94:1680 -1687.
22. Fischer W. 2011. Assembly and molecular mode of action of the Helicobacter pylori Cag type IV secretion apparatus. FEBS J. 278:1203-1212.
23. Franco AT, et al. 2008. Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. Cancer Res. 68:379 -387.
24. Furuta Y, Yahara K, Hatakeyama M, Kobayashi I. 2011. Evolution of cagA oncogene of Helicobacter pylori through recombination. PLoS One 6:e23499.
25. Gangwer KA, et al. 2010. Molecular evolution of the Helicobacter pylori vacuolating toxin gene vacA. J. Bacteriol. 192:6126-6135.
26. Hatakeyama M. 2011. Anthropological and clinical implications for the structural diversity of the Helicobacter pylori CagA oncoprotein. Cancer Sci. 102:36-43.
27. Hatakeyama M. 2004. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat. Rev. Cancer 4:688-694.
28. Hatakeyama M. 2008. SagA of CagA in Helicobacter pylori pathogenesis. Curr. Opin. Microbiol. 11:30 -37.
29. Hatakeyama M, Higashi H. 2005. Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis. Cancer Sci. 96:835- 843.
30. Higashi H, et al. 2002. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc. Natl. Acad. Sci. U. S. A. 99:14428 -14433.
31. Higashi H, et al. 2002. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 295:683- 686.
32. Jones KR, et al. 2009. Polymorphism in the CagA EPIYA motif impacts development of gastric cancer. J. Clin. Microbiol. 47:959 -968.
33. Jones KR, Whitmire JM, Merrell DS. 2010. A tale of two toxins: Helicobacter pylori CagA and VacA modulate host pathways that impact disease. Front. Microbiol. 1:115.
34. Kersulyte D, et al. 2010. Helicobacter pylori from Peruvian Amerindians: traces of human migrations in strains from remote Amazon, and genome sequence of an Amerind strain. PLoS One 5:e15076.
35. Linz B, et al. 2007. An African origin for the intimate association between humans and Helicobacter pylori. Nature 445:915-918.
36. Mane SP, et al. 2010. Host-interactive genes in Amerindian Helicobacter pylori diverge from their Old World homologs and mediate inflammatory responses. J. Bacteriol. 192:3078 -3092.
37. McClain MS, Shaffer CL, Israel DA, Peek RM, Jr., Cover TL. 2009. Genome sequence analysis of Helicobacter pylori strains associated with gastric ulceration and gastric cancer. BMC Genomics 10:3.
38. Miura M, Ohnishi N, Tanaka S, Yanagiya K, Hatakeyama M. 2009. Differential oncogenic potential of geographically distinct Helicobacter pylori CagA isoforms in mice. Int. J. Cancer 125:2497-2504.
39. Moodley Y, Linz B. 2009. Helicobacter pylori sequences reflect past human migrations. Genome Dyn. 6:62-74.
40. Naito M, et al. 2006. Influence of EPIYA-repeat polymorphism on the phosphorylation-dependent biological activity of Helicobacter pylori CagA. Gastroenterology 130:1181-1190.
41. Nesić D, et al. 2010. Helicobacter pylori CagA inhibits PAR1-MARK fam-ily kinases by mimicking host substrates. Nat. Struct. Mol. Biol. 17:130- 132.
42. Odenbreit S, et al. 2000. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 287:1497-1500.
43. Ohnishi N, et al. 2008. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc. Natl. Acad. Sci. U. S. A. 105:1003-1008.
44. Olbermann P, et al. 2010. A global overview of the genetic and functional diversity in the Helicobacter pylori cag pathogenicity island. PLoS Genet. 6:e1001069.
45. Oldani A, et al. 2009. Helicobacter pylori counteracts the apoptotic action of its VacA toxin by injecting the CagA protein into gastric epithelial cells. PLoS Pathog. 5:e1000603.
46. Posada D. 2003. Using MODELTEST and PAUP* to select a model of nucleotide substitution. Curr. Protoc. Bioinformatics 6.5.1- 6.5.14. doi: 10.1002/0471250953.bi0605s00.
47. Rozas J, Sanchez-DelBarrio JC, Messeguer X, Rozas R. 2003. DnaSP, DNApolymorphism analyses by the coalescent and other methods. Bioinformatics 19:2496 -2497.
48. Schneider TD, Stephens RM. 1990. Sequence logos: a new way to display consensus sequences. Nucleic Acids Res. 18:6097- 6100.
49. Shiota S, Matsunari O, Yamaoka Y. 2010. Relationship between J-Western CagA subtype and the vacA m2 region of Helicobacter pylori. J. Clin. Microbiol. 48:3033-3034.
50. Stein M, Rappuoli R, Covacci A. 2000. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc. Natl. Acad. Sci. U. S. A. 97:1263-1268.
51. Suerbaum S, Josenhans C. 2007. Helicobacter pylori evolution and phenotypic diversification in a changing host. Nat. Rev. Microbiol. 5:441- 452.
52. Suerbaum S, Michetti P. 2002. Helicobacter pylori infection. N. Engl. J. Med. 347:1175-1186.
53. Suerbaum S, et al. 1998. Free recombination within Helicobacter pylori. Proc. Natl. Acad. Sci. U. S. A. 95:12619 -12624.
54. Suzuki M, et al. 2011. Attenuated CagA oncoprotein in Helicobacter pylori from Amerindians in Peruvian Amazon. J. Biol. Chem. 286:29964 -29972.
55. Suzuki M, et al. 2009. Helicobacter pylori CagA phosphorylationindependent function in epithelial proliferation and inflammation. Cell Host Microbe 5:23-34.
56. Tamura K, Dudley J, Nei M, Kumar S. 2007. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol. Biol. Evol. 24:1596 -1599.
57. Tegtmeyer N, Wessler S, Backert S. 2011. Role of the cag-pathogenicity island encoded type IV secretion system in Helicobacter pylori pathogenesis. FEBS J. 278:1190 -1202.
58. Tegtmeyer N, et al. 2009. Importance of EGF receptor, HER2/Neu and Erk1/2 kinase signalling for host cell elongation and scattering induced by the Helicobacter pylori CagA protein: antagonistic effects of the vacuolating cytotoxin VacA. Cell Microbiol. 11:488 -505.
59. Thompson JD, Higgins DG, Gibson TJ. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673- 4680.
60. Torres-Morquecho A, Giono-Cerezo S, Camorlinga-Ponce M, Vargas-Mendoza CF, Torres J. 2010. Evolution of bacterial genes: evidences of positive Darwinian selection and fixation of base substitutions in virulence genes of Helicobacter pylori. Infect. Genet. Evol. 10:764 -776.
61. Truong BX, et al. 2009. Diverse characteristics of the CagA gene of Helicobacter pylori strains collected from patients from southern Vietnam with gastric cancer and peptic ulcer. J. Clin. Microbiol. 47:4021- 4028.
62. Tummuru MK, Cover TL, Blaser MJ. 1993. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect. Immun. 61:1799 -1809.
63. Waterhouse AM, Procter JB, Martin DM, Clamp M, Barton GJ. 2009. Jalview Version 2-a multiple sequence alignment editor and analysis workbench. Bioinformatics 25:1189 -1191.
64. Yamazaki S, et al. 2005. Distinct diversity of vacA, cagA, and cagE genes of Helicobacter pylori associated with peptic ulcer in Japan. J. Clin. Microbiol. 43:3906 -3916.
65. Yokoyama K, et al. 2005. Functional antagonism between Helicobacter pylori CagA and vacuolating toxin VacA in control of the NFAT signaling pathway in gastric epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 102:9661- 9666.